Ardour Capital Upgrades Metabolix (MBLX) to Hold

Ardour Capital has just upgraded Metabolix (NASDAQ: MBLX) in a mid-day research note Wednesday afternoon. The firm now rates the stock a Hold, up from Reduce previously; a $2.50 price target was maintained.

The upgrade follows a Q4 beat from Metabolix Tuesday afternoon.

While the firm liked Metabolix's "progress with its renewed commercialization efforts for its PHA technology," "solid" progress is needed before a Buy rating can be given.

For an analyst ratings summary and ratings history on Metabolix click here. For more ratings news on Metabolix click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Vireo Growth completes acquisition of C21 Investments
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions